The Harrington Male Reproductive Medicine Program (MRMP) is a world-leading clinical and research center dedicated to advancing male gestational science. Founded in 2008, our interdisciplinary team has spent nearly two decades developing and refining protocols that make male gestation a safe, evidence-based clinical reality.
Every patient receives a tailored clinical plan developed by a multidisciplinary team, supported by our dedicated Patient Navigator service from initial consultation through postpartum recovery.
Patient Information Our ResearchOur HUOI procedure uses a patient's own pluripotent stem cells to cultivate a functional gestational organoid, implanted into the peritoneal cavity for full-term gestation.
Learn About HUOI โPatients choose between Cesarean Extraction (CE) and Transanal Assisted Delivery (TAD) โ two clinically validated pathways with comparable safety profiles.
View Delivery Options โPatients select from IUI, IVF-ET, or Natural Insemination (NI) pathways โ all preceded by comprehensive genetic screening and hormonal preparation.
View Clinical Pathway โOver 210 peer-reviewed publications since 2010, 14 active NIH R01 grants, and $62M in research funding. Our investigators are advancing every aspect of male gestational medicine.
Explore Our ResearchThe program celebrated a landmark achievement as the 300th patient delivered a healthy infant via the Cesarean Extraction pathway.
Read More โA new paper in Nature Biomedical Engineering describes a novel approach reducing organoid rejection rates by 41%.
Read More โA five-year R01 grant will support expansion of the Transanal Assisted Delivery pathway with 200 additional participants.
Read More โ